<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28915855</article-id>
<article-id pub-id-type="pmc">5602921</article-id>
<article-id pub-id-type="publisher-id">464</article-id>
<article-id pub-id-type="doi">10.1186/s12881-017-0464-x</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Massive parallel sequencing as a new diagnostic approach for phenylketonuria and tetrahydrobiopterin-deficiency in Thailand</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chaiyasap</surname>
<given-names>Pongsathorn</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ittiwut</surname>
<given-names>Chupong</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Srichomthong</surname>
<given-names>Chalurmpon</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sangsin</surname>
<given-names>Apiruk</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5679-7547</contrib-id>
<name>
<surname>Suphapeetiporn</surname>
<given-names>Kanya</given-names>
</name>
<address>
<phone>662-256-4989</phone>
<email>kanya.su@chula.ac.th</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shotelersuk</surname>
<given-names>Vorasuk</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0244 7875</institution-id><institution-id institution-id-type="GRID">grid.7922.e</institution-id><institution>Center of Excellence for Medical Genetics, Department of Pediatrics, </institution><institution>Faculty of Medicine, Chulalongkorn University, </institution></institution-wrap>Bangkok, 10330 Thailand </aff>
<aff id="Aff2"><label>2</label>Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, 10330 Thailand </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9039 7662</institution-id><institution-id institution-id-type="GRID">grid.7132.7</institution-id><institution>Department of Orthopedics, </institution><institution>Faculty of Medicine, Chiang Mai University, </institution></institution-wrap>Chiang Mai, 50200 Thailand </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9758 8584</institution-id><institution-id institution-id-type="GRID">grid.411628.8</institution-id><institution>Division of Medical Genetics and Metabolism, Department of Pediatrics, </institution><institution>Sor Kor Building 11th floor, King Chulalongkorn Memorial Hospital, </institution></institution-wrap>Bangkok, 10330 Thailand </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>16</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>16</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>18</volume>
<elocation-id>102</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Hyperphenylalaninemia (HPA) can be classified into phenylketonuria (PKU) which is caused by mutations in the phenylalanine hydroxylase (<italic>PAH</italic>) gene, and BH4 deficiency caused by alterations in genes involved in tetrahydrobiopterin (BH4) biosynthesis pathway<italic>.</italic> Dietary restriction of phenylalanine is considered to be the main treatment of PKU to prevent irreversible intellectual disability. However, the same dietary intervention in BH4 deficiency patients is not as effective, as BH4 is also a cofactor in many neurotransmitter syntheses.</p>
</sec>
<sec>
<title>Method</title>
<p id="Par2">We utilized next generation sequencing (NGS) technique to investigate four unrelated Thai patients with hyperphenylalaninemia.</p>
</sec>
<sec>
<title>Result</title>
<p id="Par3">We successfully identified all eight mutant alleles in PKU or BH4-deficiency associated genes including three novel mutations, one in <italic>PAH</italic> and two in <italic>PTS</italic>, thus giving a definite diagnosis to these patients. Appropriate management can then be provided.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par4">This study identified three novel mutations in either the <italic>PAH</italic> or <italic>PTS</italic> gene and supported the use of NGS as an alternative molecular genetic approach for definite diagnosis of hyperphenylalaninemia, thus leading to proper management of these patients in Thailand.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Next generation sequencing</kwd>
<kwd>Exome</kwd>
<kwd>Hyperphenylalaninemia</kwd>
<kwd>Phenylketonuria</kwd>
<kwd>Tetrahydrobiopterin deficiency</kwd>
<kwd>Newborn screening</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004396</institution-id>
<institution>Thailand Research Fund</institution>
</institution-wrap>
</funding-source>
<award-id>BRG5980001</award-id>
<principal-award-recipient>
<name>
<surname>Suphapeetiporn</surname>
<given-names>Kanya</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par10">Phenylketonuria (PKU) is an autosomal recessive metabolic disorder, characterized by progressive intellectual disability, mousy odor, autism, seizures, eczema and motor deficits [<xref ref-type="bibr" rid="CR1">1</xref>]. The incidence of PKU in Caucasians is approximately 1:10,000 births [<xref ref-type="bibr" rid="CR2">2</xref>]. Early diagnosis of the disease is beneficial since intellectual disability can be prevented by certain therapeutic intervention [<xref ref-type="bibr" rid="CR3">3</xref>]. Generally, measuring blood phenylalanine levels provides a reliable and practical diagnosis for PKU. If the blood levels of phenylalanine exceed 120 μmol/l (2 mg/dl), the individual is considered to be hyperphenylalaninemia (HPA) and needs further diagnosis [<xref ref-type="bibr" rid="CR4">4</xref>]. The majority of Caucasian patients with excessive phenylalanine levels are classified as classic PKU (MIM#261600), which is caused by loss-of-function mutations in the phenylalanine-4-hydroxylase (<italic>PAH</italic>) gene. About 2% of Caucasian cases are BH4-deficient [<xref ref-type="bibr" rid="CR5">5</xref>], caused by mutations in the genes involved in BH4 biosynthesis consisting of 6-pyruvoyl-tetrahydropterin synthase (<italic>PTS</italic>), GTP cyclohydrolase I (<italic>GCH1</italic>), quinoiddihydropteridine reductase (<italic>QDPR</italic>), pterin-4-alpha-carbinolamine dehydratase 1 <italic>(PCBD1</italic>), and sepiapterin reductase (<italic>SPR</italic>) [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]. Interestingly, the incidence of PKU in Thailand is much less with a report of 1:212,535 in newborns [<xref ref-type="bibr" rid="CR8">8</xref>] and the proportion of Thai patients with HPA who have BH4 deficiency remains unknown.</p>
<p id="Par11">Although both PKU and BH4-deficiency patients show high blood phenylalanine levels and progressive intellectual disability, they respond to the treatment differently. Patients with PKU need additional supplement and are required to follow a diet that limits food with high phenylalanine such as dairy products, eggs, meat and fish [<xref ref-type="bibr" rid="CR9">9</xref>]. This diet therapy is highly recommended to continue throughout their life to prevent behavioral disorders, cognitive, and emotional dysfunction [<xref ref-type="bibr" rid="CR10">10</xref>]. On the other hand, patients with BH4 deficiency require BH4 supplement, generally 2–20 mg/kg/day [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], as BH4 is also a cofactor in neurotransmitter synthesis, such as dopamine, serotonin, norepinephrine and epinephrine. Thus, deficiency of BH4 leads to not only elevated phenylalanine levels, but also deficiencies of these neurotransmitters [<xref ref-type="bibr" rid="CR11">11</xref>]. Therefore, it is important for physicians to give an early and precise diagnosis, whether HPA patients are PKU or BH4-deficiency, to provide a proper treatment to the patients.</p>
<p id="Par12">Neonatal screening for PKU in Thailand was started in 1996 by Department of Medical Sciences, Ministry of Public Health, aiming to early detect and provide treatment to PKU patients through a screening program [<xref ref-type="bibr" rid="CR8">8</xref>]. The newborns’ blood samples were collected by heel prick on filter paper which was subsequently tested using the Guthrie method and/or the fluorometric method. The positive cases underwent plasma amino acid analysis using high performance liquid chromatography to determine phenylalanine levels [<xref ref-type="bibr" rid="CR13">13</xref>]. Determination of urinary pterin levels can be used to screen BH4-deficiency. Unfortunately, it is not an integral part of newborn screening in Thailand, which may lead to late diagnosis in some cases [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par13">Conventional genetic diagnosis for PKU and BH4 deficiency relies on Sanger sequencing of the entire coding regions of the responsible genes. A total of 42 exons of PKU, BH4-deficiency associated genes are needed to be analyzed. This approach is time consuming and labor intensive [<xref ref-type="bibr" rid="CR14">14</xref>]. In contrast to Sanger sequencing, next-generation sequencing (NGS) can provide high throughput information from massive parallel sequencing from a single procedure [<xref ref-type="bibr" rid="CR15">15</xref>] which is faster and more efficient. This technology has been widely used for research purpose but increasingly applied for genetic diagnosis, including PKU and BH4-deficiency [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p id="Par14">In this study, we apply next generation sequencing technique to investigate four unrelated Thai patients with hyperphenylalaninemia. The disease-causing variants were identified in all patients.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Patients</title>
<p id="Par15">Patients I, II, III and IV are children from four unrelated non-consanguineous families. Their neonatal phenylalanine screening levels were 21.4, 53.11, 37.9, and 42.6 mg/dl, respectively (normal &lt;20 mg/dl). After the diagnosis of hyperphenylalaninemia, all patients were treated with low-phenylalanine diet. For those diagnosed with BH4 deficiency, BH4 supplement was given. More clinical details are in Table <xref ref-type="table" rid="Tab1">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical and molecular findings</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Patient</th><th>I</th><th>II</th><th></th><th>III</th><th></th><th>IV</th><th></th></tr></thead><tbody><tr><td>Sex</td><td>F</td><td>M</td><td></td><td>F</td><td></td><td>F</td><td></td></tr><tr><td>Age at definite diagnosis (mo)</td><td>1</td><td>21</td><td></td><td>6</td><td></td><td>1</td><td></td></tr><tr><td>Age at last visit (mo)</td><td>51</td><td>36</td><td></td><td>16</td><td></td><td>5</td><td></td></tr><tr><td>Development</td><td>normal</td><td>delayed</td><td></td><td>normal</td><td></td><td>normal</td><td></td></tr><tr><td>Mutated gene</td><td>
<italic>PAH</italic>
</td><td>
<italic>PTS</italic>
</td><td>
<italic>PTS</italic>
</td><td>
<italic>PTS</italic>
</td><td>
<italic>PTS</italic>
</td><td>
<italic>PAH</italic>
</td><td>
<italic>PAH</italic>
</td></tr><tr><td>Genomic position (hg19)</td><td>12:103,248,934</td><td>11:112,099,388</td><td>11:112,101,362</td><td>11:112,103,916</td><td>11:112,104,166</td><td>12:103,234,294</td><td>12:103,249,009</td></tr><tr><td>dbSNP ID</td><td>novel</td><td>rs104894275</td><td>rs370340361</td><td>novel</td><td>novel</td><td>known [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td>rs62514927 [<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td>Zygosity</td><td>homozygous</td><td>compound het</td><td>compound het</td><td>compound het</td><td>compound het</td><td>compound het</td><td>compound het</td></tr><tr><td>Reference allele (REF)</td><td>–</td><td>A</td><td>C</td><td>A</td><td>A</td><td>C</td><td>T</td></tr><tr><td>Alternate allele (ALT)</td><td>T</td><td>G</td><td>T</td><td>C</td><td>G</td><td>G</td><td>C</td></tr><tr><td>No. reads with REF in proband</td><td>0</td><td>25</td><td>55</td><td>21</td><td>14</td><td>114</td><td>55</td></tr><tr><td>No. reads with ALT in proband</td><td>51</td><td>31</td><td>46</td><td>16</td><td>5</td><td>101</td><td>33</td></tr><tr><td>Mutation type</td><td>frameshift ins</td><td>missense</td><td>missense</td><td>missense</td><td>missense</td><td>splice acceptor</td><td>exonic splicing enhancer</td></tr><tr><td>cDNA change</td><td>c.686_687insA</td><td>c.155A &gt; G</td><td>c.200C &gt; T</td><td>c.274A &gt; C</td><td>c.326A &gt; G</td><td>c.1200-1G &gt; C</td><td>c.611A &gt; G</td></tr><tr><td>Protein change</td><td>p.Asp229Glufs*54</td><td>p.Asn52Ser</td><td>p.Thr67Met</td><td>p.Asn92His</td><td>p.Asn109Ser</td><td>N/A</td><td>p.Tyr204Cys</td></tr><tr><td>Prediction SIFT</td><td>N/A</td><td>damaging</td><td>damaging</td><td>damaging</td><td>damaging</td><td>N/A</td><td>damaging</td></tr><tr><td>Prediction PROVEAN</td><td>N/A</td><td>deleterious</td><td>deleterious</td><td>deleterious</td><td>deleterious</td><td>N/A</td><td>neutral</td></tr></tbody></table></table-wrap>
</p>
<p id="Par16">Written informed consent for genetic analysis was obtained from the parents of the patients.</p>
</sec>
<sec id="Sec4">
<title>Exome sequencing</title>
<p id="Par17">Three milliliters of peripheral blood were taken from each patient after informed consent. Genomic DNA was extracted by using Gentra Puregene Blood Kit, Qiagen (Qiagen, Hilden, Germany). The extraction process was done according to the manufacturer’s protocol. Genomic DNA from four patients were sent for exome sequencing using service from Macrogen, Inc. (Seuol, South Korea). The samples were prepared according to Agilent SureSelect Target Enrichment Kit (Agilent Technologies, Santa Clara, CA) preparation guide. The captured libraries were sequenced with Illumina HiSeq 2000 or HiSeq2500 Sequencer. The result sequences were aligned to the human genome reference sequence (UCSC hg19) using Burrows-Wheeler Alignment (bwa-0.7.10, <ext-link ext-link-type="uri" xlink:href="http://bio-bwa.sourceforge.net/">http://bio-bwa.sourceforge.net/</ext-link>) [<xref ref-type="bibr" rid="CR20">20</xref>]. Picard software (picard-tools-1.118, <ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link>) was used for marking and removing duplicated sequences. Genome Analysis Toolkit (GATK3.v4, <ext-link ext-link-type="uri" xlink:href="https://www.broadinstitute.org/gatk/">https://www.broadinstitute.org/gatk/</ext-link>) [<xref ref-type="bibr" rid="CR21">21</xref>] was used for data quality assessment, genotyping and variant calling. Finally, SnpEff_v.4.1 (<ext-link ext-link-type="uri" xlink:href="http://snpeff.sourceforge.net/">http://snpeff.sourceforge.net/</ext-link>) [<xref ref-type="bibr" rid="CR22">22</xref>] was used for variant annotation.</p>
</sec>
<sec id="Sec5">
<title>Genotype analysis</title>
<p id="Par18">All homozygous and compound heterozygous variants with &lt;1% allele frequency in global population and located on genes associated with hyperphenylalaninemia (<italic>PAH, PTS, GCH1, QDPR, PCBD1, SPR</italic> and <italic>GCHFR</italic>) were included. The variants with &gt;1% of the 165 unrelated Thai exomes, our in-house database, were excluded. The novel variants were confirmed by Sanger sequencing. The patients’ genomic DNA was amplified by polymerase chain reaction (PCR), using primers specific to the site of the mutation (Table <xref ref-type="table" rid="Tab2">2</xref>). The PCR products were then sent for Sanger sequencing by Macrogen Inc. (Seoul, South Korea). The sequences were analyzed by Gene Codes Sequencer software (v.5.4.1) (Gene Codes Corporation, MI). The sequencing data were compared to unaffected control sequences. ClustalX 2.1 (<ext-link ext-link-type="uri" xlink:href="http://www.clustal.org/clustal2/">http://www.clustal.org/clustal2/</ext-link>) [<xref ref-type="bibr" rid="CR23">23</xref>] was used for amino acid conservative analysis. ExAC Browser: Exome Aggregation Consortium Database (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>) was used to confirm the novelty of the variants [<xref ref-type="bibr" rid="CR24">24</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Primer sequences for Sanger sequencing of novel mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Primer name</th><th>Sequence</th><th>Tm (°C)</th></tr></thead><tbody><tr><td>
<italic>PAH</italic>_E6_F</td><td>5′-GAT GGC AGC TCA CAG GTT CT-3′</td><td>60.5</td></tr><tr><td>
<italic>PAH</italic>_E6_R</td><td>5′-CTT GTC TTC CCC TTC CCT CT-3′</td><td>60.5</td></tr><tr><td>
<italic>PTS</italic>_E5-6_F</td><td>5′-TGA TAA GGT GAG GTT TAG AGG C-3′</td><td>60.1</td></tr><tr><td>
<italic>PTS</italic>_E5-6_R</td><td>5′-CTC CAG AGC ACA ATG TGT ACG-3’</td><td>61.2</td></tr></tbody></table></table-wrap>
</p>
</sec>
</sec>
<sec id="Sec6">
<title>Results</title>
<p id="Par19">All four patients showed approximately 20,000 DNA variants across the exome (Table <xref ref-type="table" rid="Tab3">3</xref>). Mutation analysis successfully identified all eight mutant alleles in PKU or BH4-deficiency associated genes. Patients I and IV had mutations in the <italic>PAH</italic> gene, while Patients II and III had mutations in the <italic>PTS</italic> gene. The detailed characteristics of the mutations are summarized in Table <xref ref-type="table" rid="Tab1">1</xref>. Sanger sequencing of the novel mutations confirmed the presence of the mutations found by exome sequencing (Fig. <xref ref-type="fig" rid="Fig1">1a</xref> and <xref ref-type="fig" rid="Fig1">b</xref>). The amino acid alignment from ClustalX revealed that the two novel missense mutations in the <italic>PTS</italic> gene identified in Patient III were highly conserved (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Summary of exome sequencing data of the patients from each family</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th>Patient I</th><th>Patient II</th><th>Patient III</th><th>Patient IV</th></tr></thead><tbody><tr><td>Mean coverage depth of target regions (X)</td><td>60×</td><td>64×</td><td>47×</td><td>76×</td></tr><tr><td>% of captured regions with coverage &gt;10</td><td>97%</td><td>96%</td><td>96%</td><td>94%</td></tr><tr><td>Total number of coding SNPs</td><td>19,887</td><td>19,543</td><td>19,599</td><td>22,514</td></tr><tr><td>Total number of coding INDELs</td><td>472</td><td>472</td><td>469</td><td>619</td></tr><tr><td>Number of homozygous variants<sup>a</sup>
</td><td>1</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Number of compound heterozygous variants<sup>a</sup>
</td><td>0</td><td>2</td><td>2</td><td>2</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Only variants with population allele frequency &lt; 1%, and located in <italic>PAH, PTS, GCH1, QDPR, PCBD1, SRP</italic> and <italic>GCHFR</italic> were counted. Variants that are presented in &gt;1% of the in-house Thai exome database were not included</p></table-wrap-foot></table-wrap>
<fig id="Fig1"><label>Fig. 1</label><caption><p>Chromatogram of novel mutations in Patient I (<bold>a</bold>) and Patient III (<bold>b</bold>) and amino acid conservation for novel missense mutations in Patient III (<bold>c</bold>)</p></caption><graphic id="MO1" xlink:href="12881_2017_464_Fig1_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec7">
<title>Discussion</title>
<p id="Par20">Newborn screening program for HPA is important since severe intellectual disability from PKU or BH4 deficiency is preventable with proper treatment. Although Thailand has established Neonatal Screening Program for PKU for many years, screening positive patients do not undergo a test for BH4-deficiency due to the unavailability of pterin analysis in Thailand [<xref ref-type="bibr" rid="CR25">25</xref>]. In addition, BH4 loading test cannot distinguish patients with BH4 deficiency and BH4-responsive PKU [<xref ref-type="bibr" rid="CR5">5</xref>]. The conventional Sanger sequencing has been the gold standard test for a molecular approach in the genetic diagnosis of inherited disorders. This direct approach is suitable for sequencing hot-spot point mutations or small genes [<xref ref-type="bibr" rid="CR26">26</xref>]. However, it is rather costly and time consuming for diagnosis of genetic disorders which involve large genes or multiple genes, including genes associated with PKU and BH4-deficiency. The costs associated with NGS are rapidly decreasing. Therefore, we utilize NGS as a diagnostic tool in our study as it has been demonstrated to be effective in several previous reports [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p id="Par21">All eight mutant alleles were successfully identified. Of these, three have never been previously reported. Patient I has a novel homozygous frameshift mutation (c.686_687insA) in the <italic>PAH</italic> gene. Patient II has two compound heterozygous missense mutations (c.155A &gt; G and c.200C &gt; T) in the <italic>PTS</italic> gene. The c.155A &gt; G mutation has been previously reported in Chinese patients [<xref ref-type="bibr" rid="CR27">27</xref>] and the c.200C &gt; T in Italian patients [<xref ref-type="bibr" rid="CR28">28</xref>]. Patient III has two novel compound heterozygous missense mutations (c.274A &gt; C and c.326A &gt; G) in the <italic>PTS</italic> gene. Both mutations are predicted to be damaging and deleterious from prediction softwares, SIFT and PROVEAN. Patient IV has compound heterozygous, one exonic splice site enhancer (c.611A &gt; G) and one splice acceptor (c.1200-1G &gt; C) mutations in the <italic>PAH</italic> gene. The c.611A &gt; G mutation has been reported in Asian [<xref ref-type="bibr" rid="CR29">29</xref>] and European patients [<xref ref-type="bibr" rid="CR30">30</xref>] and the c.1200-1G &gt; C has been recently reported in Chinese patients [<xref ref-type="bibr" rid="CR18">18</xref>]. Therefore, Patients I and IV were diagnosed as classic PKU and were continued on low phenylalanine diet, while Patients II and III were diagnosed with BH4-deficiency and were given BH4 supplement.</p>
<p id="Par22">In order to reduce the number of identified variants from NGS data, investigators often need to apply filtering criteria to exclude low quality variants [<xref ref-type="bibr" rid="CR31">31</xref>]. This parameter could be depth of coverage. Interestingly, one of the variants in this study at position chr11:112,104,166, c.326A &gt; G in the <italic>PTS</italic> gene has total read depth of just 19 reads, with an alternate read of only 5 reads. This can be considered as very low read depth in other studies, and may have been removed from analysis [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. We would not be able to find causative mutations in patient III if we discard this variant based on the variant quality alone. In addition, despite no consanguinity history in all four families, Patient I has a frameshift homozygous mutation in the <italic>PAH</italic> gene. From additional interview, it appeared that both of her parents came from the same district of the same province. It might not be uncommon for patients with non-consanguineous parents to have homozygous mutations.</p>
<p id="Par23">Patients II and III received BH4 therapy after the definite diagnosis was made. Patient II however had delayed development and recurrent seizure treated with anticonvulsive drugs, phenytoin and levetiracetam. At his last visit when he was three years old, he still had delayed development and occasional abnormal movement (orofacial dyskinesia and chorea). This might be due to the age of Patient II when diagnosed, which was one year and nine months old. On the other hand, Patient III was given BH4 supplement at the age of 6 months after the diagnosis was made. The patient showed normal development at her last visit when she was one year and four months old. This demonstrated the importance of providing early and precise diagnosis to HPA patients.</p>
<p id="Par24">Only 2% of Caucasian patients with HPA are BH4 deficient. Interestingly, of our four consecutive patients, two are BH4 deficient. The total number of patients are very small. However, since the treatment to prevent intellectual deficit is different between both types, it is warrant to determine the proportion of PAH and BH4 deficiency among Thai patients with HPA. If a significant percentage of Thai patients with HPA have BH4 deficiency, it should be justified to perform genetic testing using NGS as soon as HPA is identified.</p>
</sec>
<sec id="Sec8">
<title>Conclusion</title>
<p id="Par25">This report represents the first study in Thailand to successfully use next-generation sequencing to detect causative mutations in PKU and BH4-deficiency cases, which allow physicians to provide a precise diagnosis and proper effective treatment to the patients. This approach is ready to substitute conventional sequencing for genetic diagnosis of patients with hyperphenylalaninemia.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>BH4</term>
<def>
<p id="Par5">tetrahydrobiopterin</p>
</def>
</def-item>
<def-item>
<term>HPA</term>
<def>
<p id="Par6">hyperphenylalaninemia</p>
</def>
</def-item>
<def-item>
<term>NGS</term>
<def>
<p id="Par7">next generation sequencing</p>
</def>
</def-item>
<def-item>
<term>PAH</term>
<def>
<p id="Par8">phenylalanine hydroxylase</p>
</def>
</def-item>
<def-item>
<term>PKU</term>
<def>
<p id="Par9">phenylketonuria</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<p>We would like to thank the patients and family members for participating in this study.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par26">This research is supported by RachadapisekSompote Fund for Postdoctoral Fellowship, Chulalongkorn Academic Advancement into Its second Century Project, Chulalongkorn University, and Thailand Research Fund (BRG5980001).</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par27">The data sets supporting the results of this article are available in the NCBI SRA database, which can be accessed via NCBI BioProject repository (accession number: PRJNA401212, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/401212">https://www.ncbi.nlm.nih.gov/bioproject/401212</ext-link>).</p>
<p id="Par28">BioSample accession numbers: SAMN07599868, SAMN07599869, SAMN07599870, SAMN07599871.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>PC, KS and VS conceived and designed the experiments. Clinical data were collected by KS and VS. PC, CS and CI performed genetic analysis. Data analysis and interpretation were performed by PC, CI, AS, KS and VS. PC, CS and AS were responsible for drafting the manuscript. KS and VS critically revised the manuscript. All authors read and approved the final version of the manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p id="Par30">Ethical approval was obtained from the institutional review board, Faculty of Medicine, Chulalongkorn University. The written informed consent for genetic analysis was obtained from the parents of the patients.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par31">The parents gave permission for the publication of the patient’s clinical details and images.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par29">The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p id="Par32">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawashima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kawano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Masaki</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Three cases of untreated classical PKU: a report on cataracts and brain calcification</article-title>
<source/>Am J Med Genet
          <year>1988</year>
<volume>29</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1320290111</pub-id>
<pub-id pub-id-type="pmid">3344778</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matalon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Michals</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Phenylketonuria: screening, treatment and maternal PKU</article-title>
<source/>Clin Biochem
          <year>1991</year>
<volume>24</volume>
<issue>4</issue>
<fpage>337</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1016/0009-9120(91)80008-Q</pub-id>
<pub-id pub-id-type="pmid">1959225</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Hafid</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Phenylketonuria: a review of current and future treatments</article-title>
<source/>Transl Pediatr
          <year>2015</year>
<volume>4</volume>
<issue>4</issue>
<fpage>304</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">26835392</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waisbren</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Noel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fahrbach</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cella</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Frame</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dorenbaum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis</article-title>
<source/>Mol Genet Metab
          <year>2007</year>
<volume>92</volume>
<issue>1–2</issue>
<fpage>63</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2007.05.006</pub-id>
<pub-id pub-id-type="pmid">17591452</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hennermann</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Langenbeck</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Lichter-Konecki</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies</article-title>
<source/>Mol Genet Metab
          <year>2011</year>
<volume>104</volume>
<issue>Suppl</issue>
<fpage>S2</fpage>
<lpage>S9</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymgme.2011.08.017</pub-id>
<pub-id pub-id-type="pmid">21937252</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thony</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase</article-title>
<source/>Hum Mutat
          <year>2006</year>
<volume>27</volume>
<issue>9</issue>
<fpage>870</fpage>
<lpage>878</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20366</pub-id>
<pub-id pub-id-type="pmid">16917893</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Grabli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cazeneuve</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Roze</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Castelnau</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chabrol</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Landrieu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ponsot</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Abada</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia</article-title>
<source/>Brain
          <year>2009</year>
<volume>132</volume>
<issue>Pt 7</issue>
<fpage>1753</fpage>
<lpage>1763</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awp084</pub-id>
<pub-id pub-id-type="pmid">19491146</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pangkanon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ratrisawadi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Charoensiriwatana</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Techasena</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Boonpuan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Srisomsap</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Svasti</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Phenylketonuria detected by the neonatal screening program in Thailand</article-title>
<source/>Southeast Asian J Trop Med Public Health
          <year>2003</year>
<volume>34</volume>
<issue>Suppl 3</issue>
<fpage>179</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="pmid">15906730</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Acosta</surname>
<given-names>PB</given-names>
</name>
</person-group>
<source/>Nutrition management of patients with inherited metabolic disorders
          <year>2010</year>
<publisher-loc>Sudbury, Mass</publisher-loc>
<publisher-name>Jones and Bartlett Publishers</publisher-name>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stemerdink</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Kalverboer</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>van der Meere</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>van der Molen</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Huisman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>de Jong</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Slijper</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Verkerk</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>van Spronsen</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Behaviour and school achievement in patients with early and continuously treated phenylketonuria</article-title>
<source/>J Inherit Metab Dis
          <year>2000</year>
<volume>23</volume>
<issue>6</issue>
<fpage>548</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="doi">10.1023/A:1005669610722</pub-id>
<pub-id pub-id-type="pmid">11032330</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shintaku</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Disorders of tetrahydrobiopterin metabolism and their treatment</article-title>
<source/>Curr Drug Metab
          <year>2002</year>
<volume>3</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.2174/1389200024605145</pub-id>
<pub-id pub-id-type="pmid">12003346</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias</article-title>
<source/>Expert Opin Drug Metab Toxicol
          <year>2013</year>
<volume>9</volume>
<issue>9</issue>
<fpage>1207</fpage>
<lpage>1218</lpage>
<pub-id pub-id-type="pmid">23705856</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pangkanon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Charoensiriwatana</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Janejai</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Boonwanich</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Chaisomchit</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Detection of phenylketonuria by the newborn screening program in Thailand</article-title>
<source/>Southeast Asian J Trop Med Public Health
          <year>2009</year>
<volume>40</volume>
<issue>3</issue>
<fpage>525</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="pmid">19842439</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trujillano</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tornador</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Navarrete</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Escaramis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ossowski</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Armengol</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cornejo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Desviat</surname>
<given-names>LR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin-deficient hyperphenylalaninemias using high-throughput targeted sequencing</article-title>
<source/>Eur J Hum Genet
          <year>2014</year>
<volume>22</volume>
<issue>4</issue>
<fpage>528</fpage>
<lpage>534</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2013.175</pub-id>
<pub-id pub-id-type="pmid">23942198</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majewski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schwartzentruber</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lalonde</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Montpetit</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jabado</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>What can exome sequencing do for you?</article-title>
<source/>J Med Genet
          <year>2011</year>
<volume>48</volume>
<issue>9</issue>
<fpage>580</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100223</pub-id>
<pub-id pub-id-type="pmid">21730106</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation spectrum of six genes in Chinese phenylketonuria patients obtained through next-generation sequencing</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<issue>4</issue>
<fpage>e94100</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0094100</pub-id>
<pub-id pub-id-type="pmid">24705691</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Correlation between genotype and the tetrahydrobiopterin-responsive phenotype in Chinese patients with phenylketonuria</article-title>
<source/>Pediatr Res
          <year>2015</year>
<volume>78</volume>
<issue>6</issue>
<fpage>691</fpage>
<lpage>699</lpage>
<pub-id pub-id-type="doi">10.1038/pr.2015.167</pub-id>
<pub-id pub-id-type="pmid">26322415</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing</article-title>
<source/>Sci Rep
          <year>2015</year>
<volume>5</volume>
<fpage>15769</fpage>
<pub-id pub-id-type="doi">10.1038/srep15769</pub-id>
<pub-id pub-id-type="pmid">26503515</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutational spectrum of phenylketonuria in Jiangsu province</article-title>
<source/>Eur J Pediatr
          <year>2015</year>
<volume>174</volume>
<issue>10</issue>
<fpage>1333</fpage>
<lpage>1338</lpage>
<pub-id pub-id-type="doi">10.1007/s00431-015-2539-z</pub-id>
<pub-id pub-id-type="pmid">25894915</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Fast and accurate short read alignment with burrows-wheeler transform</article-title>
<source/>Bioinformatics
          <year>2009</year>
<volume>25</volume>
<issue>14</issue>
<fpage>1754</fpage>
<lpage>1760</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
<pub-id pub-id-type="pmid">19451168</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sivachenko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cibulskis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kernytsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Garimella</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Altshuler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<issue>9</issue>
<fpage>1297</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
<pub-id pub-id-type="pmid">20644199</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cingolani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Platts</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang le</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Land</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ruden</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila Melanogaster strain w1118; iso-2; iso-3</article-title>
<source/>Fly (Austin)
          <year>2012</year>
<volume>6</volume>
<issue>2</issue>
<fpage>80</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.4161/fly.19695</pub-id>
<pub-id pub-id-type="pmid">22728672</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larkin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Blackshields</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Chenna</surname>
<given-names>R</given-names>
</name>
<name>
<surname>McGettigan</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>McWilliam</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Valentin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Wilm</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clustal W and Clustal X version 2.0</article-title>
<source/>Bioinformatics
          <year>2007</year>
<volume>23</volume>
<issue>21</issue>
<fpage>2947</fpage>
<lpage>2948</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id>
<pub-id pub-id-type="pmid">17846036</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Minikel</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>T</given-names>
</name>
<name>
<surname>O'Donnell-Luria</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>BB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature
          <year>2016</year>
<volume>536</volume>
<issue>7616</issue>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vatanavicharn</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kuptanon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liammongkolkul</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Ratanarak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wasant</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Novel mutation affecting the pterin-binding site of PTS gene and review of PTS mutations in Thai patients with 6-pyruvoyltetrahydropterin synthase deficiency</article-title>
<source/>J Inherit Metab Dis
          <year>2009</year>
<volume>32</volume>
<issue>Suppl 1</issue>
<fpage>S279</fpage>
<lpage>S282</lpage>
<pub-id pub-id-type="doi">10.1007/s10545-009-1221-x</pub-id>
<pub-id pub-id-type="pmid">19830588</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsanis</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Katsanis</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Molecular genetic testing and the future of clinical genomics</article-title>
<source/>Nat Rev Genet
          <year>2013</year>
<volume>14</volume>
<issue>6</issue>
<fpage>415</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3493</pub-id>
<pub-id pub-id-type="pmid">23681062</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Identification of a common 6-pyruvoyl-tetrahydropterin synthase mutation at codon 87 in Chinese phenylketonuria caused by tetrahydrobiopterin synthesis deficiency</article-title>
<source/>Hum Genet
          <year>1996</year>
<volume>98</volume>
<issue>3</issue>
<fpage>313</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1007/s004390050213</pub-id>
<pub-id pub-id-type="pmid">8707300</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oppliger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Thony</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kluge</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Matasovic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heizmann</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Ponzone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Spada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Blau</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Identification of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency in four Italian families</article-title>
<source/>Hum Mutat
          <year>1997</year>
<volume>10</volume>
<issue>1</issue>
<fpage>25</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1098-1004(1997)10:1&lt;25::AID-HUMU4&gt;3.0.CO;2-L</pub-id>
<pub-id pub-id-type="pmid">9222757</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okano</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Eisensmith</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>SZ</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>YT</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Missense mutations prevalent in Orientals with phenylketonuria: molecular characterization and clinical implications</article-title>
<source/>Genomics
          <year>1991</year>
<volume>10</volume>
<issue>2</issue>
<fpage>449</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1016/0888-7543(91)90331-8</pub-id>
<pub-id pub-id-type="pmid">2071149</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellingsen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Knappskog</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Eiken</surname>
<given-names>HG</given-names>
</name>
</person-group>
<article-title>Phenylketonuria splice mutation (EXON6nt-96A--&gt;g) masquerading as missense mutation (Y204C)</article-title>
<source/>Hum Mutat
          <year>1997</year>
<volume>9</volume>
<issue>1</issue>
<fpage>88</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1098-1004(1997)9:1&lt;88::AID-HUMU21&gt;3.0.CO;2-K</pub-id>
<pub-id pub-id-type="pmid">8990021</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Bayrak-Toydemir</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Deignan</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Friez</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Funke</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Hegde</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ACMG clinical laboratory standards for next-generation sequencing</article-title>
<source/>Genet Med
          <year>2013</year>
<volume>15</volume>
<issue>9</issue>
<fpage>733</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2013.92</pub-id>
<pub-id pub-id-type="pmid">23887774</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform</article-title>
<source/>J Med Genet
          <year>2011</year>
<volume>48</volume>
<issue>11</issue>
<fpage>731</fpage>
<lpage>736</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100133</pub-id>
<pub-id pub-id-type="pmid">21969337</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Broman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kleinschnitz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Rost</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Islander</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>Next-generation DNA sequencing of a Swedish malignant hyperthermia cohort</article-title>
<source/>Clin Genet
          <year>2015</year>
<volume>88</volume>
<issue>4</issue>
<fpage>381</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12508</pub-id>
<pub-id pub-id-type="pmid">25256590</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>